François Habersetzer

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Fabrice Carrat, Hélène Fontaine, Céline Dorival et al. · The Lancet · 2019 · 631 citations · Full text

Pharmacy, Pharmacotherapy, Outcomes Research +13

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells

Vedashree Ramakrishnaiah, Christine Thumann, Isabel Fofana et al. · Proceedings of the National Academy of Sciences · 2013 · 495 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12